Archive | Life Science ETF’s and Mutual Funds RSS feed for this section

Another Big Rally on Europe Non-News: Biotech Sector Lagging

Another stealth rally led by financials took the S&P 500 up 2% helped by a turbo boost in the last 90 minutes as The Guardian reported that France and Germany agreed to boost the rescue fund.Oil prices rebounded driving energy shares higher. Some pundits as well as EU officials were skeptical of the Guardian news [...]

1 Comment Continue Reading →

Life Science Stocks Rally into the Third Day Up Over 2%

Risk is on for Life Science Stocks The rally that began late tuesday continued into the third day with major biotech indices up over 2%.The Rayno Life Science Portfolio was up 2.2% with recent reiterated buys up even more: AMRI, EXAS, GPRO, OPTR,  REGN, SGEN, and VPHM.  Illumina (ILMN $39.93) was off 0.2% and the [...]

Comments Off Continue Reading →

Sell-Off Breaks Through August 9 Technical Bottom: Biotechs Weak

Concerns About The Global Economy And Massive Debt Bring Us To Bear Market Boundaries The first day of the fourth quarter of 2011 held out hope for a new market direction, but the relentless selling from Q3 persisted with the major averages off more than 2.5%. The market tried to rally in the first two [...]

Comments Off Continue Reading →

Rally Rolls Over: Trading Range Intact-Biotech Outperforms in September

A 2.7+% rally faded today as European debt crisis  headlines put a damper on optimism. Many of the pundits were skeptical of the rally saying it was driven by short covering. Biotechs Outperforming This Month With all of this volatility you’d think we found a trend. But the three day rally has only brought the [...]

Comments Off Continue Reading →

Nasty Day Reminds Us: The FED is Running Out of Juice

S&P Sells Off 2.94%-Caution Comes Back as Market is Down 4% in 3 Trading Days Something happened, but maybe we were just reminded that the economic picture is still grim and monetary policy has done what it can. Europe is still a time bomb with funding for Greece  not resolved and even Italy on the [...]

Comments Off Continue Reading →

Healthcare Sector Gets Upgrade from Morgan Stanley

Biotechnology,Pharmaceuticals and Healthcare Providers Are Most Attractive After a five day rally led by chips, tech and industrials Morgan Stanley came out today calling the healthcare sector an overweight. Adam Parker, the US Equity Strategist published a report with the key themes and top picks by the US Healthcare Team. In a detailed 25 page [...]

Comments Off Continue Reading →